Erika F. Lindarte
Medellin, ANT, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: July 05, 2023
Vitamin D supplementation for children with mild to moderate asthma: an economic evaluation.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: February 09, 2023
Effectiveness of high-dose vitamin D supplementation to reduce the incidence rate of repeat episodes of pneumonia in children: A systematic review.
Journal: Pediatric pulmonology
Published: December 22, 2022
Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis.
Journal: Value in health regional issues
Published: July 24, 2022
Comparison of three alternatives for the management of moderate asthma in children aged 6-11 years: a cost-utility analysis.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: July 05, 2022
Ambrisentan for in pediatric pulmonary arterial hypertension: A cost-utility analysis.
Journal: Pediatric pulmonology
Published: June 04, 2022
OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis.
Journal: BMC pulmonary medicine
Published: March 21, 2022
Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis.
Journal: BMC pulmonary medicine
Published: February 19, 2022
TLR4 Gene Polymorphisms Interaction With Ascaris Infection in Severe RSV Bronchiolitis.
Journal: Frontiers in pediatrics
Published: February 16, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026